Previous studies suggested that SNF2L enhances tumorigenesis in breast cancer cells by inhibiting DNA damage and promoting cell growth, while in gastric cancer, it is associated with maintaining cellular homeostasis [20]. The gene discussed is SMARCA1; the disease is breast carcinoma.